OGD/OND system will help share reviews
The Office of Generic Drugs is adopting a new information technology system that will enable it to share reviews with the Office of New Drugs, allowing both offices "full access to all available information of approved drug products," FDA announces Oct. 6. The new electronic Division File System provides OGD "document management, tracking, archiving, and electronic signature capabilities for internally generated review documents and search and retrieval capabilities for final versions of internally generated documents." FDA hopes the improved electronic repository for ANDA review and regulatory documents will improve the efficiency of the generic review process; OGD's mounting application backlog has come under fire over the last year (1"The Pink Sheet" Feb. 13, 2006, p. 7)...
You may also be interested in...
FDA is reducing the percentage of generic drug applications for which it aims to shorten review time
If President Trump appoints, and the Senate approves, a new conservative justice for the Supreme Court to replace Ruth Bader Ginsberg, Affordable Care Act coverage could disappear. See what Kyle Sampson, a partner with the Washington, DC law firm King & Spalding said about it here.
Join us for an audio roundup of major events in the global biopharma industry over the past week, as reported by Scrip.